Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study

Abstract Background To examine serum angiopoietin-2 (Angpt-2) in relation to malnutrition, inflammation, atherosclerosis and cardiac valvular calcification, so-called MIAC syndrome and its predictive role in outcomes of peritoneal dialysis (PD) patients. Methods A prospective observational study was...

Full description

Bibliographic Details
Main Authors: Xiaoxiao Yang, He Zhang, Yuanyuan Shi, Zanzhe Yu, Hao Yan, Zhaohui Ni, Jiaqi Qian, Wei Fang
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Journal of Translational Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12967-018-1687-0
_version_ 1818954600750776320
author Xiaoxiao Yang
He Zhang
Yuanyuan Shi
Zanzhe Yu
Hao Yan
Zhaohui Ni
Jiaqi Qian
Wei Fang
author_facet Xiaoxiao Yang
He Zhang
Yuanyuan Shi
Zanzhe Yu
Hao Yan
Zhaohui Ni
Jiaqi Qian
Wei Fang
author_sort Xiaoxiao Yang
collection DOAJ
description Abstract Background To examine serum angiopoietin-2 (Angpt-2) in relation to malnutrition, inflammation, atherosclerosis and cardiac valvular calcification, so-called MIAC syndrome and its predictive role in outcomes of peritoneal dialysis (PD) patients. Methods A prospective observational study was conducted in 324 chronic PD patients. Biochemical analysis was performed at baseline for serum angiopoietins, albumin and high sensitive C-reactive protein (hs-CRP) and echocardiography was done to detect cardiac valvular calcification. Primary study end points were fatal or nonfatal cardiovascular events and mortality. Results The median of serum Angpt-2 levels was 5.44 ng/mL (interquartile range, 3.41–7.85). Across the three tertiles of serum Angpt-2, a significant trend effect was observed for body mass index, normalized protein catabolic rate, calcium × phosphorus product, hs-CRP, brain natriuretic peptide, lower-density lipoprotein cholesterol, left ventricular ejection fraction, total weekly urea clearance and residual renal function (all p < 0.05). Serum Angpt-2 showed a significant increase across the four groups of patients with increasing components of MIAC syndrome (p < 0.001). There were 77 deaths and 57 cardiovascular events. High serum Angpt-2 was an independent predictor of fatal and nonfatal cardiovascular events in PD patients (p = 0.02), however serum Angpt-2 was not an independent predictor of all-cause mortality (p = 0.3). Conclusions Serum Angpt-2 showed close association with valvular calcification, atherosclerosis, inflammation and malnutrition, having significant independent prognostic value and is useful for cardiovascular event stratification in chronic PD patients. Angpt-2 might be a potential mediator of increased cardiovascular risk in patients undergoing PD treatment.
first_indexed 2024-12-20T10:24:45Z
format Article
id doaj.art-810bbcd4702045cabbfc48be72597f63
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-12-20T10:24:45Z
publishDate 2018-11-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-810bbcd4702045cabbfc48be72597f632022-12-21T19:43:51ZengBMCJournal of Translational Medicine1479-58762018-11-0116111110.1186/s12967-018-1687-0Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort studyXiaoxiao Yang0He Zhang1Yuanyuan Shi2Zanzhe Yu3Hao Yan4Zhaohui Ni5Jiaqi Qian6Wei Fang7Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityAbstract Background To examine serum angiopoietin-2 (Angpt-2) in relation to malnutrition, inflammation, atherosclerosis and cardiac valvular calcification, so-called MIAC syndrome and its predictive role in outcomes of peritoneal dialysis (PD) patients. Methods A prospective observational study was conducted in 324 chronic PD patients. Biochemical analysis was performed at baseline for serum angiopoietins, albumin and high sensitive C-reactive protein (hs-CRP) and echocardiography was done to detect cardiac valvular calcification. Primary study end points were fatal or nonfatal cardiovascular events and mortality. Results The median of serum Angpt-2 levels was 5.44 ng/mL (interquartile range, 3.41–7.85). Across the three tertiles of serum Angpt-2, a significant trend effect was observed for body mass index, normalized protein catabolic rate, calcium × phosphorus product, hs-CRP, brain natriuretic peptide, lower-density lipoprotein cholesterol, left ventricular ejection fraction, total weekly urea clearance and residual renal function (all p < 0.05). Serum Angpt-2 showed a significant increase across the four groups of patients with increasing components of MIAC syndrome (p < 0.001). There were 77 deaths and 57 cardiovascular events. High serum Angpt-2 was an independent predictor of fatal and nonfatal cardiovascular events in PD patients (p = 0.02), however serum Angpt-2 was not an independent predictor of all-cause mortality (p = 0.3). Conclusions Serum Angpt-2 showed close association with valvular calcification, atherosclerosis, inflammation and malnutrition, having significant independent prognostic value and is useful for cardiovascular event stratification in chronic PD patients. Angpt-2 might be a potential mediator of increased cardiovascular risk in patients undergoing PD treatment.http://link.springer.com/article/10.1186/s12967-018-1687-0Angiopoietin-2AtherosclerosisCalcificationInflammationMalnutritionPeritoneal dialysis
spellingShingle Xiaoxiao Yang
He Zhang
Yuanyuan Shi
Zanzhe Yu
Hao Yan
Zhaohui Ni
Jiaqi Qian
Wei Fang
Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study
Journal of Translational Medicine
Angiopoietin-2
Atherosclerosis
Calcification
Inflammation
Malnutrition
Peritoneal dialysis
title Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study
title_full Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study
title_fullStr Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study
title_full_unstemmed Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study
title_short Association of serum angiopoietin-2 with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients: a prospective cohort study
title_sort association of serum angiopoietin 2 with malnutrition inflammation atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients a prospective cohort study
topic Angiopoietin-2
Atherosclerosis
Calcification
Inflammation
Malnutrition
Peritoneal dialysis
url http://link.springer.com/article/10.1186/s12967-018-1687-0
work_keys_str_mv AT xiaoxiaoyang associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy
AT hezhang associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy
AT yuanyuanshi associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy
AT zanzheyu associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy
AT haoyan associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy
AT zhaohuini associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy
AT jiaqiqian associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy
AT weifang associationofserumangiopoietin2withmalnutritioninflammationatherosclerosisandvalvularcalcificationsyndromeandoutcomeinperitonealdialysispatientsaprospectivecohortstudy